Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.
Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.
Not yet recruiting · NCT07518329 · Registry updated 2026-08-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia. | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Phase 1 | 2026-08-06 | NCT07518329 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Arovella Therapeutics Ltd | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Epworth Healthcare | Richmond | Australia | 13 |
| Mater Misericordiae Ltd (MML) | Brisbane | Australia | 1 |
| Royal Adelaide Hospital | Adelaide | Australia | 132 |
| St. Vincent's Hospital | Sydney | Australia | 4 |
| The Alfred Hospital | Melbourne | Australia | 110 |